TAK1 inhibition elicits mitochondrial ROS to block intracellular bacterial colonization

Area of Science:

• Immunology
• Cellular Microbiology
• Host-Pathogen Interactions

Background:

• Mitogen-activated protein kinase kinase kinase 7 (MAP3K7), or TAK1, is a key signaling intermediate in inflammatory responses.
• Previous studies suggested TAK1 ablation exacerbates inflammation and reactive oxygen species (ROS) due to impaired tissue integrity.
• This study challenges the notion that TAK1's role is solely in tissue maintenance.

Purpose of the Study:

• To investigate the role of TAK1 inhibition-induced ROS in host defense against intracellular bacteria.
• To elucidate the mechanism by which host cells target intracellular pathogens via TAK1 signaling.
• To identify host factors involved in this novel defense pathway.

Main Methods:

• Utilized mouse models with targeted Tak1 gene deletions.
• Investigated the role of bacterial effector proteins, such as Yersinia's YopJ, in inhibiting TAK1.
• Analyzed mitochondrial ROS production and its impact on intracellular bacterial survival.
• Examined the involvement of caspase 8 and RIPK3 in the host defense response.

Main Results:

• TAK1 inhibition, induced by bacterial effectors like YopJ, leads to mitochondrial-derived ROS production.
• These ROS effectively destroy intracellular bacteria, indicating an active host defense.
• Caspase 8 and RIPK3 were found to be crucial for mediating TAK1 inhibition-induced ROS and inhibiting bacterial growth.
• This defense mechanism is triggered by the host's recognition of pathogen-induced impairment of TAK1, not direct pathogen recognition.

Conclusions:

• TAK1 inhibition by intracellular bacteria activates a novel host defense mechanism involving ROS.
• This pathway highlights an indirect recognition strategy where host cells target pathogen-induced host protein dysfunction.
• Caspase 8 and RIPK3 play a critical role in this ROS-mediated bacterial clearance.